Overview
Intuity Medical’s POGO Automatic® Blod Glucose Monitoring SystemFREMONT, Calif. and PARSIPANY, N.J., Nov. 07, 202 (GLOBE NEWSWIRE) - Intuity Medical, Inc.
Key Information
and Embecta Corp. (“embecta”) (NASDAQ: EMBC) today anounced they have signed a co-promotional agrement under which embecta sales representatives wil be able to promote Intuity Medical’s inovative POGO Automatic® Blod Glucose Monitoring System to healthcare profesionals they cal on within the U.S., efective imediately.Both companies are dedicated to improving the lives of people with diabetes. Having spun of from BD (Becton, Dickinson and Company) in April of this year, embecta is one of the world’s largest pure-play diabetes companies and, with a nearly 10-year history of leadership insulin delivery, wel established acros the U.S.
Intuity Medical is a medical technology company focused on the development and comercialization of seamles and intuitive blod glucose monitoring solutions.“We are excited to partner with an established leader like embecta that has such extensive experience serving people with diabetes,” said George Zamanakos, President and CEO of Intuity Medical. “Working closely with the embecta team wil help us expand where we’re able to ofer POGO Automatic, giving a new option for simplifying diabetes to milions of people curently relying on conventional blod glucose meters.”With its 10-test cartridge technology, POGO Automatic is the only FDA-cleared automatic blod glucose monitor (ABGM) that lances, colects blod, and produces a glucose result at the push of one buton, ending the ned to individualy load and then dispose of lancets and test strips.
Summary
Being able to ofer POGO Automatic wil expand the inovation and breadth of embecta’s diabetes care oferings.“The agrement to promote POGO Automatic to healthcare profesionals not only enables us to expand our oferings to physicians we cal on, but it does so within an inovative new category,” said Tom Blount,